CIK: 0001703031
Total reported value
$1.1B
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | SWTXUSD | Springworks Therapeutics INC | Stock-Other | 32.03% | — | — | |
| 2 | ARQT | Arcutis Biotherapeutics INC | Stock-Other | 12.60% | — | — | |
| 3 | DRNAUSD | Dicerna Pharmaceuticals INC | Stock-Other | 10.85% | — | — | |
| 4 | DVAX | Dynavax Technologies CORP | Stock-Other | 10.12% | — | +24.80% | |
| 5 | ✓ | Mersana Therapeutics INC | Stock-Other | 8.44% | — | — | |
| 6 | REPL | Replimune Group INC | Stock-Other | 5.63% | — | -23.82% | |
| 7 | CNST | Constellation Pharmaceutical | Stock-Other | 4.41% | — | -36.47% | |
| 8 | AGLEUSD | Aeglea Biotherapeutics INC | Stock-Other | 2.62% | — | — | |
| 9 | ✓ | Aptinyx INC | Stock-Other | 2.43% | — | — | |
| 10 | SVRA | Savara INC | Stock-Other | 2.41% | +0.54% | — | |
| 11 | SG7 | Sage Therapeutics INC | Stock-Other | 2.17% | — | — | |
| 12 | CRNX | Crinetics Pharmaceuticals In | Stock-Other | 1.97% | — | — | |
| 13 | ASNSUSD | X4 Pharmaceuticals INC | Stock-Other | 1.61% | — | — | |
| 14 | MRNSUSD | Marinus Pharmaceuticals INC | Stock-Other | 1.52% | — | -3.68% | |
| 15 | SLDB | Solid Biosciences Inc. | Stock-Other | 1.19% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | DVAX | Dynavax Technologies CORP | +4.9% | +24.80% | Add |
| 2 | REPL | Replimune Group INC | +0.8% | -23.82% | Trim |
| 3 | ✓ | Aptinyx INC | +0.4% | — | Unchanged |
| 4 | SLDB | Solid Biosciences Inc. | -0.4% | — | Unchanged |
| 5 | MRNSUSD | Marinus Pharmaceuticals INC | -0.5% | -3.68% | Trim |
| 6 | ASNSUSD | X4 Pharmaceuticals INC | -1.2% | — | Unchanged |
| 7 | SWTXUSD | Springworks Therapeutics INC | -1.2% | — | Unchanged |
| 8 | SVRA | Savara INC | -1.5% | — | Unchanged |
| 9 | DRNAUSD | Dicerna Pharmaceuticals INC | -1.8% | — | Unchanged |
| 10 | CNST | Constellation Pharmaceutical | -7.3% | -36.47% | Trim |
| 11 | ARQT | Arcutis Biotherapeutics INC | -7.5% | — | Unchanged |
| 12 | ✓ | Mersana Therapeutics INC | — | NEW | New buy |
| 13 | AGLEUSD | Aeglea Biotherapeutics INC | — | NEW | New buy |
| 14 | SG7 | Sage Therapeutics INC | — | NEW | New buy |
| 15 | CRNX | Crinetics Pharmaceuticals In | — | NEW | New buy |